is semaglutide under patent Dr. Reddy's Laboratories gearing up to launch its generic injection in March, reportedly the brand name #Obeda, as protection expires in 2025, according to Reuters. Semaglutide, the key GLP-1 maker jumps on patent

Other ingredients Water (aqua), glycerin, peg-8, niacinamide, butylene glycol, methylpropanediol, 1,2-hexanediol, methyl gluceth-20, glycereth-26, bis-peg-18 methyl ether di methyl silane, betaine, carbomer, diphenyl dimethicone, tromethamine, triethylhexanoin, ethylhexylglycerin, c12-14 alketh-12, fragrance, glutathione, xanthan gum, hydrogenated lecithin, adenosine, coptis japonica extract, polyglyceryl-10 oleate, disodium edta, saccharide hydro lysate, polyglyceryl-10 laurate, panthenol, collagen, theobroma cacao (cocoa) seed extract, dextrin, sodium hyaluronate, stellaria media (chickweed) extract, sorbitan laurate, prunella vulgaris extra ct, lactobacillus ferment, fucus vesiculosus extract, hydroxyethylcellulose, acetyl dipeptide-1 cetyl ester, lycopodium clavatum extract, equisetum arvense extract, caprylyl glycol, hyaluronic ac id, palmitoyl tripeptide-5, sodium hyaluronate crosspolymer, hydrolyzed sodium hyaluronate, hydrolyzed hyaluronic ac id, acetyl octapeptide-3, sodium acetylated hyaluronate, hydroxypropyltrimonium hyaluronate, hydrolyzed keratin, hydrolyzed collagen, hydrolyzed silk

The goal of a maintenance protocol is to soften the landing

We assist with zepbound prior authorization and other weight loss medications, letting us manage all aspects of the treatment

Source: US Department of Agriculture, Agricultural Research Service